UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL people

Group by: Type | Date
Number of items: 136.

Article

Ainley, L; Chavda, SJ; Counsell, N; Cheesman, S; Newrick, F; Horder, J; Kyriakou, C; ... Yong, K; + view all (2021) DT‐PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation. British Journal of Haematology , 192 (3) e73-e77. 10.1111/bjh.17248. Green open access
file

Alaggio, Rita; Amador, Catalina; Anagnostopoulos, Ioannis; Attygalle, Ayoma D; Araujo, Iguaracyra Barreto de Oliveira; Berti, Emilio; Bhagat, Govind; ... Xiao, Wenbin; + view all (2022) The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 10.1038/s41375-022-01620-2. (In press). Green open access
file

Asher, Samir; Kazantzi, Aikaterini; Dekaj, Fatjon; Steventon, Luke; Khatun, Aisha; Ainley, Louise; McMillan, Annabel; ... Popat, Rakesh; + view all (2022) Under-representation of ethnic minorities in early phase clinical trials for multiple myeloma. Haematologica , 107 (12) pp. 2961-2965. 10.3324/haematol.2022.281322. Green open access
file

Baggiano, A; Boldrini, M; Martinez-Naharro, A; Kotecha, T; Petrie, A; Rezk, T; Gritti, M; ... Fontana, M; + view all (2020) Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis. JACC: Cardiovascular Imaging , 13 (1(1)) pp. 69-80. 10.1016/j.jcmg.2019.03.026. Green open access
filefile

Banypersad, SM; Fontana, M; Maestrini, V; Sado, DM; Captur, G; Petrie, A; Piechnik, SK; ... Moon, JC; + view all (2015) T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J , 36 (4) 244 - 251. 10.1093/eurheartj/ehu444. Green open access
file

Bomsztyk, Joshua; Khwaja, Jahanzaib; Wechalekar, Ashutosh D; (2022) Recent guidelines for high-dose chemotherapy and autologous stem cell transplant for systemic AL amyloidosis: a practitioner's perspective. Expert Review of Hematology 10.1080/17474086.2022.2115353. (In press). Green open access
file

Bomsztyk, Joshua; Ravichandran, Sriram; Giles, Hannah Victoria; Wright, Nicola Jane; Berlanga, Oscar; Khwaja, Jahanzaib; Mahmood, Shameem; ... Wechalekar, Ashutosh D; + view all (2024) Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis. Blood , 143 (13) pp. 1259-1268. 10.1182/blood.2023022399. Green open access
file

Boyle, EM; Ashby, C; Wardell, CP; Rowczenio, D; Sachchithanantham, S; Wang, Y; Johnson, SK; ... Wechalekar, AD; + view all (2018) The genomic landscape of plasma cells in systemic light chain amyloidosis. Blood , 132 (26) pp. 2775-2777. 10.1182/blood-2018-08-872226. Green open access
file

Carr, AS; Shah, S; Choi, D; Blake, J; Phadke, R; Gilbertson, J; Whelan, CJ; ... Reilly, MM; + view all (2019) Spinal Stenosis in Familial Transthyretin Amyloidosis. Journal of Neuromuscular Diseases 10.3233/JND-180348. (In press). Green open access
filefile

Chacko, L; Boldrini, M; Martone, R; Law, S; Martinez-Naharrro, A; Hutt, DF; Kotecha, T; ... Fontana, M; + view all (2021) Cardiac Magnetic Resonance–Derived Extracellular Volume Mapping for the Quantification of Hepatic and Splenic Amyloid. Circulation: Cardiovascular Imaging , 14 (4) , Article e012506. 10.1161/CIRCIMAGING.121.012506. Green open access
file

Chacko, L; Martone, R; Bandera, F; Lane, T; Martinez-Naharro, A; Boldrini, M; Rezk, T; ... Fontana, M; + view all (2020) Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis. European Heart Journal , 41 (14) pp. 1439-1447. 10.1093/eurheartj/ehz905. Green open access
file

Chavda, SJ; Pocock, R; Cheesman, S; Lee, K-M; Dowling, E; Marks, DJB; Kyriakou, C; ... Popat, R; + view all (2020) Association of hypertension and cardiac events in patients with multiple myeloma receiving carfilzomib: practical management recommendations. British Journal of Haematology 10.1111/bjh.16889. (In press). Green open access
file

Cheng, Richard; Kittleson, Michelle M; Wechalekar, Ashutosh D; Alvarez-Cardona, Jose; Mitchell, Joshua D; Macedo, Ariane Vieira Scarlatelli; Dutra, Joao Pedro Passos; ... Lenihan, Daniel; + view all (2024) Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society statement. Heart 10.1136/heartjnl-2023-323502. (In press). Green open access
file

Cohen, Oliver; Rendas-Baum, Regina; McCausland, Kristen; Foard, Darren; Manwani, Richa; Ravichandran, Sriram; Lachmann, Helen; ... Wechalekar, Ashutosh; + view all (2023) Linking changes in quality of life to haematologic response and survival in systemic immunoglobulin light-chain amyloidosis. British Journal of Haematology , 201 (3) pp. 422-431. 10.1111/bjh.18645. Green open access
file

Cohen, Oliver C; Ismael, Andreia; Pawarova, Babita; Manwani, Richa; Ravichandran, Sriram; Law, Steven; Foard, Darren; ... Wechalekar, Ashutosh D; + view all (2022) Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis. European Heart Journal , 43 (4) pp. 333-341. 10.1093/eurheartj/ehab507. Green open access
file

Cohen, Oliver C; Sathyanath, Ananth; Petrie, Aviva; Ravichandran, Sriram; Law, Steven; Manwani, Richa; Foard, Darren; ... Wechalekar, Ashutosh D; + view all (2022) Prognostic importance of the 6 min walk test in light chain (AL) amyloidosis. Heart , 108 (20) pp. 1616-1622. 10.1136/heartjnl-2021-320703. Green open access
file

Cohen, OC; Brodermann, MH; Blakeney, IJ; Mahmood, S; Sachchithanantham, S; Ravichandran, S; Law, S; ... Wechalekar, AD; + view all (2020) Rapid response to single agent daratumumab is associated with improved progression-free survival in relapsed/refractory AL amyloidosis. Amyloid , 27 (3) pp. 200-205. 10.1080/13506129.2020.1765768. Green open access
file

Cohen, OC; Law, S; Lachmann, HJ; Sharpley, F; Ravichandran, S; Mahmood, S; Sachchithanantham, S; ... Wechalekar, AD; + view all (2020) The impact and importance of achieving a complete haematological response prior to renal transplantation in AL amyloidosis. Blood Cancer Journal , 10 (5) , Article 60. 10.1038/s41408-020-0325-2. Green open access
file

Cohen, OC; Sharpley, F; Gilbertson, JA; Wechalekar, AD; Sachchithanantham, S; Mahmood, S; Whelan, CJ; ... Gillmore, JD; + view all (2020) The value of screening biopsies in light chain (AL) and transthyretin (ATTR) amyloidosis. European Journal of Haematology , 105 (3) pp. 352-356. 10.1111/ejh.13458. Green open access
file

Cohen, OC; Sharpley, F; Gillmore, JD; Lachmann, HJ; Sachchithanantham, S; Mahmood, S; Fontana, M; ... Wechalekar, AD; + view all (2020) Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light‐chain amyloidosis. British Journal of Haematology , 189 (4) pp. 643-649. 10.1111/bjh.16401. Green open access
file

Cohen, OC; Wechalekar, AD; (2020) Systemic amyloidosis: moving into the spotlight. Leukemia , 34 (5) pp. 1215-1228. 10.1038/s41375-020-0802-4. Green open access
file

da Silva Filho, MI; Försti, A; Weinhold, N; Meziane, I; Campo, C; Huhn, S; Nickel, J; ... Hemminki, K; + view all (2017) Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma. Leukemia , 31 (8) pp. 1735-1742. 10.1038/leu.2016.387. Green open access
file

Dispenzieri, A; Kastritis, E; Wechalekar, AD; Schönland, SO; Kim, K; Sanchorawala, V; Landau, HJ; ... Merlini, G; + view all (2021) A randomized phase 3 study of ixazomib–dexamethasone versus physician’s choice in relapsed or refractory AL amyloidosis. Leukemia 10.1038/s41375-021-01317-y. (In press). Green open access
file

Fontana, M; Pica, S; Reant, P; Abdel-Gadir, A; Treibel, TA; Banypersad, SM; Maestrini, V; ... Moon, JC; + view all (2015) Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis. Circulation , 132 (16) pp. 1570-1579. 10.1161/CIRCULATIONAHA.115.016567. Green open access
file

Fox, TA; Lunn, M; Wechalekar, A; Bomanji, J; Wan, S; D'Sa, S; (2018) [18F]Florbetaben PET-CT confirms AL amyloidosis in a patient with Waldenström's Macroglobulinaemia. Haematologica , 103 (6) 10.3324/haematol.2017.184515. Green open access
file

Gertz, MA; Cohen, AD; Comenzo, RL; Kastritis, E; Landau, HJ; Libby, EN; Liedtke, M; ... Merlini, G; + view all (2023) Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial. Blood 10.1182/blood.2022019406. (In press). Green open access
file

Ghinai, RAM; Mahmood, S; Mukonoweshuro, P; Webber, S; Wechalekar, AD; Moore, SE; (2017) Diagnosing Light Chain Amyloidosis on Temporal Artery Biopsies for Suspected Giant Cell Arteritis. Journal of Neuro-Ophthalmology , 37 (1) pp. 34-39. 10.1097/WNO.0000000000000447. Green open access
file

Gillmore, JD; Maurer, MS; Falk, RH; Merlini, G; Damy, T; Dispenzieri, A; Wechalekar, AD; ... Hawkins, PN; + view all (2016) Non-Biopsy Diagnosis of Cardiac Transthyretin Amyloidosis. Circulation , 133 (24) pp. 2404-2412. 10.1161/CIRCULATIONAHA.116.021612. Green open access
filefilefilefile

Havasi, Andrea; Heybeli, Cihan; Leung, Nelson; Angel-Korman, Avital; Sanchorawala, Vaishali; Cohen, Oliver; Wechalekar, Ashutosh; ... Landau, Heather; + view all (2022) Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group. Blood Cancer Journal , 12 (8) , Article 119. 10.1038/s41408-022-00714-5. Green open access
file

Hutt, DF; Fontana, M; Burniston, M; Quigley, AM; Petrie, A; Ross, JC; Page, J; ... Gillmore, JD; + view all (2017) Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid. European Heart Journal - Cardiovascular Imaging , 18 (12) pp. 1344-1350. 10.1093/ehjci/jew325. Green open access
filefilefilefilefilefilefile

Inaugural Amyloidosis Forum Panelists, .; Lousada, I; (2020) The Amyloidosis Forum: a public private partnership to advance drug development in AL amyloidosis. Orphanet Journal of Rare Diseases , 15 (1) , Article 268. 10.1186/s13023-020-01525-2. Green open access
file

Jamroziak, Krzysztof; Zielonka, Klaudia; Khwaja, Jahanzaib; Wechalekar, Ashutosh D; (2025) Update on B-cell maturation antigen-directed therapies in AL amyloidosis. British Journal of Haematology , 206 (3) pp. 817-831. 10.1111/bjh.19960.

Kastritis, E; Palladini, G; Minnema, MC; Wechalekar, AD; Jaccard, A; Lee, HC; Sanchorawala, V; ... ANDROMEDA Trial Investigators, .; + view all (2021) Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis. New England Journal of Medicine , 385 (1) pp. 46-58. 10.1056/NEJMoa2028631. Green open access
file

Kastritis, Efstathios; Misra, Arpit; Gurskyte, Laura; Kroi, Florint; Verhoek, Andre; Vermeulen, Jessica; Ammann, Eric; ... Wechalekar, Ashutosh D; + view all (2023) Assessing the prognostic utility of hematologic response for overall survival in patients with newly diagnosed AL amyloidosis: results of a meta-analysis. Hematology , 28 (1) , Article 2157581. 10.1080/16078454.2022.2157581. Green open access
file

Kastritis, E; Leleu, X; Arnulf, B; Zamagni, E; Cibeira, MT; Kwok, F; Mollee, P; ... Palladini, G; + view all (2020) Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis. Journal of Clinical Oncology , 38 (28) pp. 3252-3260. 10.1200/JCO.20.01285. Green open access
file

Kastritis, E; Wechalekar, A; Schoenland, S; Sanchorawala, V; Merlini, G; Palladini, G; Minnema, M; ... Dimopoulos, MA; + view all (2020) Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic. British Journal of Haematology , 190 (3) pp. 346-357. 10.1111/bjh.16898. Green open access
file

Khwaja, J; D'Sa, S; Minnema, MC; Kersten, MJ; Wechalekar, A; Vos, JM; (2022) IgM monoclonal gammopathies of clinical significance: diagnosis and management. Haematologica , 107 (9) pp. 2037-2050. 10.3324/haematol.2022.280953. Green open access
file

Khwaja, Jahanzaib; Bomsztyk, Joshua; Atta, Maria; Bygrave, Ceri; Forbes, Adam; Durairaj, Senthil; Fernandes, Savio; ... Wechalekar, Ashutosh D; + view all (2024) Real-world efficacy of single-agent belantamab mafodotin in relapsed systemic AL amyloidosis. British Journal of Haematology , 204 (5) pp. 1811-1815. 10.1111/bjh.19286. Green open access
file

Khwaja, Jahanzaib; Bomsztyk, Joshua; Mahmood, Shameem; Wisniowski, Brendan; Shah, Raakhee; Tailor, Anish; Yong, Kwee; ... Wechalekar, Ashutosh D; + view all (2022) High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis. Blood Cancer Journal , 12 (9) , Article 128. 10.1038/s41408-022-00717-2. Green open access
file

Khwaja, Jahanzaib; Vos, Josephine MI; Pluimers, Tessa E; Japzon, Nicole; Patel, Aisha; Salter, Simon; Kwakernaak, Arjan J; ... D'Sa, Shirley; + view all (2024) Clinical and clonal characteristics of monoclonal immunoglobulin M-associated type I cryoglobulinaemia. British Journal of Haematology , 204 (1) pp. 177-185. 10.1111/bjh.19112. Green open access
file

Knight, DS; Zumbo, G; Barcella, W; Steeden, JA; Muthurangu, V; Martinez-Naharro, A; Treibel, TA; ... Fontana, M; + view all (2019) Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles. JACC Cardiovascular Imaging , 12 (5) pp. 823-833. 10.1016/j.jcmg.2018.02.016. Green open access
file

Kotecha, T; Martinez-Naharro, A; Treibel, TA; Francis, R; Nordin, S; Abdel-Gadir, A; Knight, DS; ... Fontana, M; + view all (2018) Myocardial Edema and Prognosis in Amyloidosis. Journal of the American College of Cardiology , 71 (25) pp. 2919-2931. 10.1016/j.jacc.2018.03.536. Green open access
file

Lane, T; Fontana, M; Martinez-Naharro, A; Quarta, CC; Whelan, CJ; Petrie, A; Rowczenio, DM; ... Gillmore, JD; + view all (2019) Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis. Circulation , 140 (1) pp. 16-26. 10.1161/CIRCULATIONAHA.118.038169. Green open access
file

Lane, T; Pinney, JH; Gilbertson, JA; Hutt, DF; Rowczenio, DM; Mahmood, S; Sachchithanantham, S; ... Lachmann, HJ; + view all (2017) Changing epidemiology of AA amyloidosis: clinical observations over 25 years at a single national referral centre. Amyloid: The Journal of Protein Folding Disorders , 24 (3) pp. 162-166. 10.1080/13506129.2017.1342235. Green open access
filefile

Lane, T; Rowczenio, DM; Gilbertson, JA; Gillmore, JD; Wechalekar, AD; Hawkins, PN; Lachmann, HJ; (2015) Empirical use of anakinra in AA amyloidosis of uncertain aetiology. Pediatric Rheumatology , 13 (Supp 1) , Article O70. 10.1186/1546-0096-13-S1-O70. Green open access
file

Lane, T; Wechalekar, AD; Gillmore, JD; Hawkins, PN; Lachmann, HJ; (2017) Safety and efficacy of empirical interleukin-1 inhibition using anakinra in AA amyloidosis of uncertain aetiology. Amyloid , 24 (3) pp. 189-193. 10.1080/13506129.2017.1352503. Green open access
file

Law, S; Cohen, O; Lachmann, H; Rezk, T; Gilbertson, J; Rowczenio, D; Wechalekar, A; ... Gillmore, J; + view all (2021) Renal Transplant Outcomes in Amyloidosis. Nephrology Dialysis Transplantation , 36 (2) pp. 355-365. 10.1093/ndt/gfaa293. Green open access
file

Law, S; Petrie, A; Chacko, L; Cohen, OC; Ravichandran, S; Gilbertson, JA; Rowczenio, D; ... Gillmore, JD; + view all (2020) Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage. ESC Heart Failure 10.1002/ehf2.12989. (In press). Green open access
file

Law, S; Petrie, A; Chacko, L; Cohen, OC; Ravichandran, S; Gilbertson, JA; Rowczenio, D; ... Gillmore, JD; + view all (2021) Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy. Heart 10.1136/heartjnl-2021-319063. (In press). Green open access
file

Leblond, V; Kastritis, E; Advani, R; Ansell, SM; Buske, C; Castillo, JJ; Garcia-Sanz, R; ... Dimopoulos, MA; + view all (2016) Treatment recommendations from the Eighth International Workshop on Waldenstrom's Macroglobulinemia. Blood , 128 (10) pp. 1321-1328. 10.1182/blood-2016-04-711234. Green open access
file

Lecat, CSY; Taube, JBB; Wilson, W; Carmichael, J; Parrish, C; Wallis, G; Kyriakou, C; ... Popat, R; + view all (2021) Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma. Frontiers in Oncology , 11 , Article 703233. 10.3389/fonc.2021.703233. Green open access
file

Leung, N; Bridoux, F; Batuman, V; Chaidos, A; Cockwell, P; D'Agati, VD; Dispenzieri, A; ... Nasr, SH; + view all (2019) The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group. Nature Reviews Nephrology , 15 (1) pp. 45-59. 10.1038/s41581-018-0077-4. Green open access
file

Luo, MM; Zhu, PP; Nnane, I; Xiong, Y; Merlini, G; Comenzo, RL; Kastritis, E; ... Zhou, H; + view all (2022) Population Pharmacokinetics and Exposure-Response Modeling of Daratumumab Subcutaneous Administration in Patients With Light-Chain Amyloidosis. The Journal of Clinical Pharmacology , 62 (5) pp. 656-669. 10.1002/jcph.1994. Green open access
file

Maciocia, N; Wechalekar, A; Yong, K; (2016) Monoclonal gammopathy of undetermined significance and smoldering myeloma (SMM): a practical guide to management. Hematological Oncology , 35 (4) pp. 432-439. 10.1002/hon.2345. Green open access
file

Mahmood, S; Sovani, M; Smith, P; George, L; Quarta, CC; Sachchithanantham, S; Fontana, M; ... Wechalekar, AD; + view all (2017) High prevalence of recurrent nocturnal desaturations in systemic AL amyloidosis: a cross-sectional pilot study. [Review]. Sleep Medicine , 32 pp. 191-197. 10.1016/j.sleep.2016.11.021. Green open access
file

Mahmood, S; Wassef, NL; Salter, SJ; Sachchithanantham, S; Lane, T; Foard, D; Whelan, CJ; ... Wechalekar, AD; + view all (2016) Comparison of Free Light Chain Assays Freelite and N Latex in Diagnosis, Monitoring, and Predicting Survival in Light Chain Amyloidosis. American Journal of Clinical Pathology , 146 (1) pp. 78-85. 10.1093/ajcp/aqw079. Green open access
file

Manwani, R; Cohen, O; Sharpley, F; Mahmood, S; Sachchithanantham, S; Foard, D; Lachmann, HJ; ... Wechalekar, AD; + view all (2019) A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib. Blood , 134 (25) pp. 2271-2280. 10.1182/blood.2019000834. Green open access
file

Manwani, R; Foard, D; Mahmood, S; Sachchithanantham, S; Lane, T; Quarta, C; Youngstein, T; ... Wechalekar, AD; + view all (2018) Rapid Hematologic Responses Improve Outcomes In Patients With Very Advanced (Stage IIIb) Cardiac Immunoglobulin Light Chain Amyloidosis. Haematologica , 103 (4) e165-e168. 10.3324/haematol.2017.178095. Green open access
file

Manwani, R; Hegenbart, U; Mahmood, S; Sachchithanantham, S; Kyriakou, C; Yong, K; Popat, R; ... Wechalekar, A; + view all (2018) Deferred autologous stem cell transplantation in systemic AL amyloidosis. Blood Cancer Journal , 8 , Article 101. 10.1038/s41408-018-0137-9. Green open access
file

Manwani, R; Mahmood, S; Sachchithanantham, S; Lachmann, HJ; Gillmore, JD; Yong, K; Rabin, N; ... Wechalekar, AD; + view all (2019) Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy. British Journal of Haematology , 187 (5) pp. 638-641. 10.1111/bjh.16122. Green open access
file

Manwani, R; Page, J; Lane, T; Burniston, M; Skillen, A; Lachmann, HJ; Gillmore, JD; ... Wechalekar, AD; + view all (2018) A pilot study demonstrating cardiac uptake with 18F-florbetapir PET in AL amyloidosis patients with cardiac involvement. Amyloid. The Journal of Protein Folding Disorders , 25 (4) pp. 247-252. 10.1080/13506129.2018.1552852. Green open access
file

Manwani, R; Sachchithanantham, S; Mahmood, S; Foard, D; Sharpley, F; Rezk, T; Lane, T; ... Wechalekar, AD; + view all (2018) Treatment of IgM-associated immunoglobulin light chain amyloidosis with Rituximab-Bendamustine. Blood 10.1182/blood-2018-04-846493. (In press). Green open access
file

Manwani, R; Wrench, D; Wechalekar, A; Lachmann, H; (2018) Successful treatment of systemic AA amyloidosis associated with underlying Hodgkin lymphoma. British Journal of Haematology , 182 (5) p. 619. 10.1111/bjh.15269. Green open access
file

Martinez-Naharro, Ana; Patel, Rishi; Kotecha, Tushar; Karia, Nina; Ioannou, Adam; Petrie, Aviva; Chacko, Liza A; ... Fontana, Marianna; + view all (2022) Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment. European Heart Journal , 43 pp. 4722-4735. 10.1093/eurheartj/ehac363. Green open access
file

Martinez-Naharro, A; Abdel-Gadir, A; Treibel, TA; Zumbo, G; Knight, DS; Rosmini, S; Lane, T; ... Fontana, M; + view all (2018) CMR-Verified Regression of Cardiac AL Amyloid After Chemotherapy. [Letter]. JACC: Cardiovascular Imaging , 11 (1) pp. 152-154. 10.1016/j.jcmg.2017.02.012. Green open access
file

Merlini, G; Lousada, I; Ando, Y; Dispenzieri, A; Gertz, MA; Grogan, M; Maurer, MS; ... Comenzo, RL; + view all (2016) Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis. Leukemia , 30 (10) pp. 1979-1986. 10.1038/leu.2016.191. Green open access
file

Meziane, I; Huhn, S; da Silva Filho, MI; Weinhold, N; Campo, C; Nickel, J; Hoffmann, P; ... Hemminki, K; + view all (2017) Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts. [Letter]. Haematologica , 102 (10) e411-e414. 10.3324/haematol.2017.171108. Green open access
file

Milani, P; Sharpley, F; Schoenland, SO; Basset, M; Mahmood, S; Nuvolone, M; Kimmich, C; ... Hegenbart, U; + view all (2020) Pomalidomide and dexamethasone grant rapid haematologic responses in patients with relapsed and refractory AL amyloidosis: a European retrospective series of 153 patients. The Journal of Protein Folding Disorders , 27 (4) pp. 231-236. 10.1080/13506129.2020.1767566. Green open access
file

Minnema, MC; Dispenzieri, A; Merlini, G; Comenzo, RL; Kastritis, E; Wechalekar, AD; Grogan, M; ... Jaccard, A; + view all (2022) Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis: Phase 3 ANDROMEDA Trial. JACC: CardioOncology , 4 (4) pp. 474-487. 10.1016/j.jaccao.2022.08.011. Green open access
file

Muchtar, Eli; Dispenzieri, Angela; Wisniowski, Brendan; Palladini, Giovanni; Milani, Paolo; Merlini, Giampaolo; Schönland, Stefan; ... Gertz, Morie A; + view all (2023) Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis. Journal of Clinical Oncology , 41 (7) pp. 1393-1403. 10.1200/JCO.22.00643. Green open access
file

Muchtar, Eli; Wisniowski, Brendan; Geyer, Susan; Palladini, Giovanni; Milani, Paolo; Merlini, Giampaolo; Schönland, Stefan; ... Gertz, Morie A; + view all (2024) Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain Amyloidosis. JAMA oncology , 10 (10) pp. 1362-1369. 10.1001/jamaoncol.2024.2629. Green open access
file

Nesr, George; Shah, Raakhee; Kyriakou, Charalampia; Sive, Jonathan; Popat, Rakesh; Yong, Kwee; Wisniowski, Brendan; ... Rabin, Neil; + view all (2023) Impact of timing of stem cell return following high dose melphalan in multiple myeloma patients with renal impairment: a single center experience. Leukemia & Lymphoma 10.1080/10428194.2023.2216817. (In press). Green open access
file

Nyktari, E; Vassiliou, VS; Arzanauskaite, M; Gatehouse, P; Greiser, A; Wechalekar, A; Gilbertson, J; ... Mohiaddin, R; + view all (2017) Challenging Occam's Razor: An Unusual Combination of Sarcoidosis and Amyloidosis. The Value of Cardiac Magnetic Resonance Imaging in Infiltrative Cardiomyopathies. Canadian Journal of Cardiology , 33 (10) 1335.e9-1335.e11. 10.1016/j.cjca.2017.07.004. Green open access
file

Palladini, Giovanni; Schönland, Stefan; Merlini, Giampaolo; Milani, Paolo; Jaccard, Arnaud; Bridoux, Frank; Dimopoulos, Meletios A; ... Wechalekar, Ashutosh; + view all (2023) The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018. Blood Cancer Journal , 13 (1) , Article 19. 10.1038/s41408-023-00789-8. Green open access
file

Palladini, G; Kastritis, E; Maurer, MS; Zonder, JA; Minnema, MC; Wechalekar, AD; Jaccard, A; ... Comenzo, RL; + view all (2020) Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA. Blood , 136 (1) pp. 71-80. 10.1182/blood.2019004460. Green open access
file

Palladini, G; Paiva, B; Wechalekar, A; Massa, M; Milani, P; Lasa, M; Ravichandran, S; ... Merlini, G; + view all (2021) Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis. Blood Cancer Journal , 11 , Article 34. 10.1038/s41408-021-00428-0. Green open access
file

Papa, R; Gilbertson, JA; Rendell, N; Wechalekar, AD; Gillmore, JD; Hawkins, PN; Lachmann, HJ; (2020) Two types of systemic amyloidosis in a single patient. Amyloid , 27 (4) pp. 275-276. 10.1080/13506129.2020.1760238. Green open access
file

Patel, Rishi K; Bandera, Francesco; Venneri, Lucia; Porcari, Aldostefano; Razvi, Yousuf; Ioannou, Adam; Chacko, Liza; ... Fontana, Marianna; + view all (2024) Cardiopulmonary Exercise Testing in Evaluating Transthyretin Amyloidosis. JAMA Cardiology , 9 (4) pp. 367-376. 10.1001/jamacardio.2024.0022. Green open access
file

Phillips, EH; Nash, S; Adedayo, T; Whelan, CJ; Fontana, M; Mahmood, S; Lachmann, HJ; ... Wechalekar, AD; + view all (2017) Pitfalls in conducting prospective trials in stage III cardiac amyloidosis - experience from the REVEAL study. Amyloid , 24 (4) pp. 250-252. 10.1080/13506129.2017.1385453. Green open access
file

Pinney, JH; Smith, CJ; Taube, JB; Lachmann, HJ; Venner, CP; Gibbs, SD; Dungu, J; ... Gillmore, JD; + view all (2013) Systemic amyloidosis in England: an epidemiological study. Br J Haematol , 161 (4) 525 - 532. 10.1111/bjh.12286. Green open access
file

Premkumar, VJ; Lentzsch, S; Pan, S; Bhutani, D; Richter, J; Jagannath, S; Liedtke, M; ... Kapoor, P; + view all (2021) Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis. Blood Cancer Journal , 11 (1) , Article 10. 10.1038/s41408-020-00397-w. Green open access
file

Quarta, CC; Gonzalez-Lopez, E; Gilbertson, JA; Botcher, N; Rowczenio, D; Petrie, A; Rezk, T; ... Gillmore, JD; + view all (2017) Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis. European Heart Journal , 38 (24) pp. 1905-1908. 10.1093/eurheartj/ehx047. Green open access
file

Quarta, CC; Zheng, J; Hutt, D; Grigore, SF; Manwani, R; Sachchithanantham, S; Mahmood, SA; ... Wechalekar, AD; + view all (2021) 99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis. European Heart Journal - Cardiovascular Imaging 10.1093/ehjci/jeab095. (In press). Green open access
file

Ravichandran, S; Cohen, OC; Law, S; Sachchithanantham, S; Mahmood, S; Foard, D; Fontana, M; ... Wechalekar, AD; + view all (2021) Haematologic responses and survival do not significantly decrease with subsequent lines of therapy in systemic immunoglobulin light chain amyloidosis: results from an analysis of real-world longitudinal data. British Journal of Haematology , 194 (3) pp. 587-597. 10.1111/bjh.17636. Green open access
filefile

Ravichandran, Sriram; Hall, Andrew; Jenner, Matthew; Garg, Mamta; Kishore, Bhuvan; Lachmann, Helen; Gillmore, Julian; ... Wechalekar, Ashutosh; + view all (2023) A phase 1b dose-escalation study of carfilzomib in combination with thalidomide and dexamethasone in patients with relapsed/refractory systemic immunoglobulin light chain amyloidosis. Amyloid , 30 (3) pp. 1-7. 10.1080/13506129.2023.2169124. Green open access
filefile

Ravichandran, Sriram; Law, Steven; Mahmood, Shameem; Wisniowski, Brenden; Foard, Darren; Fontana, Marianna; Martinez-Naharro, Ana; ... Wechalekar, Ashutosh D; + view all (2022) Early relapse is an adverse prognostic marker in systemic immunoglobulin light chain (AL) Amyloidosis. Leukemia 10.1038/s41375-021-01497-7. (In press). Green open access
file

Ravichandran, Sriram; Law, Steven; Mahmood, Shameem; Wisniowski, Brenden; Foard, Darren; Fontana, Marianna; Martinez-Naharro, Ana; ... Wechalekar, Ashutosh D; + view all (2022) Long-term outcomes in light chain deposition disease- analysis of a UK cohort. American Journal of Hematology , 97 (12) E444-E446. 10.1002/ajh.26725. Green open access
file

Ravichandran, Sriram; Mahmood, Shameem; Wisniowski, Brenden; Sachchithanantham, Sajitha; Popat, Rakesh; Lachmann, Helen; Rabin, Neil; ... D Wechalekar, Ashutosh; + view all (2022) A UK consensus algorithm for early treatment modification in newly diagnosed systemic light-chain amyloidosis. British Journal of Haematology , 198 (2) pp. 328-332. 10.1111/bjh.18216. Green open access
file

Ravichandran, S; Cohen, OC; Law, S; Foard, D; Fontana, M; Martinez-Naharro, A; Whelan, C; ... Wechalekar, AD; + view all (2021) Impact of early response on outcomes in AL amyloidosis following treatment with frontline Bortezomib. Blood Cancer Journal , 11 (6) , Article 118. 10.1038/s41408-021-00510-7. Green open access
file

Ravichandran, S; Lachmann, HJ; Wechalekar, AD; (2020) Epidemiologic and Survival Trends in Amyloidosis, 1987–2019. The New England Journal of Medicine , 382 (16) pp. 1567-1568. 10.1056/NEJMc1917321. Green open access
file

Rezk, T; Davenport, A; Gan, JJ; Lachmann, HJ; Fontana, M; Martinez-Naharro, A; Sachchithanantham, S; ... Gillmore, JD; + view all (2019) Bioimpedance vector analysis for the detection of extracellular volume overload and sarcopenia in systemic AL amyloidosis. British Journal of Haematology , 185 (5) pp. 977-980. 10.1111/bjh.15675. Green open access
file

Rezk, T; Gilbertson, JA; Mangione, PP; Rowczenio, D; Rendell, N; Canetti, D; Lachmann, HJ; ... Gillmore, JD; + view all (2019) The complementary role of histology and proteomics for diagnosis and typing of systemic amyloidosis. Journal of Pathology: Clinical Research , 5 (3) pp. 145-153. 10.1002/cjp2.126. Green open access
file

Rezk, T; Gilbertson, JA; Rowczenio, D; Bass, P; Lachmann, HJ; Wechalekar, AD; Fontana, M; ... Gillmore, JD; + view all (2018) Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis. Nephrology Dialysis Transplantation , 33 (2) pp. 241-247. 10.1093/ndt/gfw375. Green open access
filefilefilefilefile

Rezk, T; Lachmann, HJ; Fontana, M; Naharro, AM; Sachchithanantham, S; Mahmood, S; Petrie, A; ... Gillmore, JD; + view all (2019) Cardiorenal AL amyloidosis: risk stratification and outcomes based upon cardiac and renal biomarkers. British Journal of Haematology , 186 (3) pp. 460-470. 10.1111/bjh.15955. Green open access
file

Rezk, T; Lachmann, HJ; Fontana, M; Sachchithanantham, S; Mahmood, S; Petrie, A; Whelan, CJ; ... Gillmore, JD; + view all (2017) Prolonged renal survival in light chain amyloidosis: speed and magnitude of light chain reduction is the crucial factor. Kidney International , 92 (6) pp. 1476-1483. 10.1016/j.kint.2017.05.004. Green open access
file

Rezk, T; Salota, R; Gan, JJ; Lachmann, HJ; Fontana, M; Siew, K; Martinez-Naharro, A; ... Gillmore, JD; + view all (2021) Urinary retinol binding protein predicts renal outcome in systemic immunoglobulin light-chain (AL) amyloidosis. British Journal of Haematology 10.1111/bjh.17706. Green open access
file

Rezk, T; Whelan, CJ; Lachmann, HJ; Fontana, M; Sachchithanantham, S; Mahmood, S; Khan, F; ... Wechalekar, AD; + view all (2017) Role of implantable intracardiac defibrillators in patients with cardiac immunoglobulin light chain amyloidosis. [Letter]. British Journal of Haematology 10.1111/bjh.14747. (In press). Green open access
filefile

Richards, DB; Cookson, LM; Barton, SV; Liefaard, L; Lane, T; Hutt, DF; Ritter, JM; ... Pepys, MB; + view all (2018) Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis. Science Translational Medecine , 10 (422) , Article eaan3128. 10.1126/scitranslmed.aan3128. Green open access
file

Ross, JC; Hutt, DF; Burniston, M; Page, J; Steeden, JA; Gillmore, JD; Wechalekar, AD; ... Fontana, M; + view all (2018) Quantitation of Tc-99m-DPD uptake in patients with transthyretin-related cardiac amyloidosis. Amyloid , 25 (3) pp. 203-210. 10.1080/13506129.2018.1520087. Green open access
file

Rowczenio, D; Quarta, CC; Fontana, M; Whelan, CJ; Martinez-Naharro, A; Trojer, H; Baginska, A; ... Lachmann, HJ; + view all (2019) Analysis of the TTR gene in the investigation of amyloidosis: A 25 year single UK centre experience. Human Mutation , 40 (1) pp. 90-96. 10.1002/humu.23669. Green open access
file

Rowczenio, D; Stensland, M; de Souza, GA; Strøm, EH; Gilbertson, JA; Taylor, G; Rendell, N; ... Wien, TN; + view all (2017) Renal Amyloidosis Associated With 5 Novel Variants in the Fibrinogen A Alpha Chain Protein. Kidney International Reports , 2 (3) pp. 461-469. 10.1016/j.ekir.2016.11.005. Green open access
file

Rowczenio, DM; Pathak, S; Arostegui, JI; Mensa-Vilaro, A; Omoyinmi, E; Brogan, P; Lipsker, D; ... Lachmann, HJ; + view all (2017) Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome. Blood , 131 (9) pp. 974-981. 10.1182/blood-2017-10-810366. Green open access
file

Sachchithanantham, S; Berlanga, O; Alvi, A; Mahmood, SA; Lachmann, HJ; Gillmore, JD; Hawkins, PN; ... Wechalekar, AD; + view all (2017) Immunoparesis defined by heavy plus light chain suppression is a novel marker of long-term outcomes in cardiac AL amyloidosis. British Journal of Haematology , 179 (4) pp. 575-585. 10.1111/bjh.14908. Green open access
file

Sachchithanantham, S; Roussel, M; Palladini, G; Klersy, C; Mahmood, S; Venner, CP; Gibbs, S; ... Wechalekar, AD; + view all (2016) European Collaborative Study Defining Clinical Profile Outcomes and Novel Prognostic Criteria in Monoclonal Immunoglobulin M-Related Light Chain Amyloidosis. Journal of Clinical Oncology , 34 (17) pp. 2037-2045. 10.1200/JCO.2015.63.3123. Green open access
file

Sanchorawala, Vaishali; Boccadoro, Mario; Gertz, Morie; Hegenbart, Ute; Kastritis, Efstathios; Landau, Heather; Mollee, Peter; ... Palladini, Giovanni; + view all (2021) Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines. Amyloid , 29 (1) 10.1080/13506129.2021.2002841. Green open access
file

Sanchorawala, Vaishali; Wechalekar, Ashutosh DD; Kim, Kihyun; Schönland, Stefan OO; Landau, Heather JJ; Kwok, Fiona; Suzuki, Kenshi; ... Kastritis, Efstathios; + view all (2023) Quality of life and symptoms among patients with relapsed/refractory AL amyloidosis treated with ixazomib-dexamethasone versus physician's choice. American Journal of Hematology 10.1002/ajh.26866. (In press). Green open access
file

Saunders, CN; Chattopadhyay, S; Huhn, S; Weinhold, N; Hoffmann, P; Noethen, MM; Joeckel, K-H; ... Hemminki, K; + view all (2021) Search for AL amyloidosis risk factors using Mendelian randomization. Blood Advances , 5 (13) pp. 2725-2731. 10.1182/bloodadvances.2021004423. Green open access
file

Sethi, S; Nast, CC; D'Agati, VD; Fervenza, FC; Glassock, RJ; Stokes, MB; De Vriese, AS; ... Haas, M; + view all (2020) Standardized reporting of monoclonal immunoglobulin-associated renal diseases: recommendations from a Mayo Clinic/Renal Pathology Society Working Group. Kidney International , 98 (2) pp. 310-313. 10.1016/j.kint.2020.03.025. Green open access
file

Sharpley, FA; Manwani, R; Petrie, A; Mahmood, S; Sachchithanantham, S; Lachmann, HJ; Martinez De Azcona Naharro, A; ... Wechalekar, AD; + view all (2021) Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first‐line treatment of systemic light chain amyloidosis in the UK. European Journal of Haematology , 106 (4) pp. 537-545. 10.1111/ejh.13582. Green open access
file

Sharpley, FA; De-Silva, D; Mahmood, S; Sachchithanantham, S; Ramsay, I; Garcia Mingo, A; Worthington, S; ... D Wechalekar, A; + view all (2020) Cytomegalovirus reactivation after bortezomib treatment for multiple myeloma and light chain amyloidosis. European Journal of Haematology , 104 (3) pp. 230-235. 10.1111/ejh.13366. Green open access
file

Sharpley, FA; Fontana, M; Gilbertson, JA; Gillmore, JD; Hawkins, PN; Mahmood, S; Manwani, R; ... Lachmann, HJ; + view all (2020) Amyloidosis Diagnosed in Solid Organ Transplant Recipients. Transplantation , 104 (2) pp. 415-420. 10.1097/TP.0000000000002813. Green open access
file

Sharpley, FA; Fontana, M; Martinez-Naharro, A; Manwani, R; Mahmood, S; Sachchithanantham, S; Lachmann, HJ; ... Wechalekar, AD; + view all (2019) Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria. Haematologica 10.3324/haematol.2019.217695. (In press). Green open access
file

Sharpley, FA; Manwani, R; Mahmood, S; Sachchithanantham, S; Lachmann, H; Gilmore, J; Whelan, C; ... Wechalekar, A; + view all (2018) Real world outcomes of pomalidomide for treatment of relapsed light chain amyloidosis. British Journal of Haematology , 183 (4) pp. 557-563. 10.1111/bjh.15541. Green open access
file

Sharpley, FA; Manwani, R; Mahmood, S; Sachchithanantham, S; Lachmann, HJ; Gillmore, JD; Whelan, CJ; ... Wechalekar, AD; + view all (2019) A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis. Blood Cancer Journal , 9 , Article 16. 10.1038/s41408-019-0180-1. Green open access
file

Sharpley, FA; Petrie, A; Mahmood, S; Sachchithanantham, S; Lachmann, HJ; Gillmore, JD; Whelan, CJ; ... Wechalekar, AD; + view all (2019) A 24-year experience of autologous stem cell transplantation for light chain amyloidosis patients in the United Kingdom. British Journal of Haematology , 187 (5) pp. 642-652. 10.1111/bjh.16143. Green open access
file

Slart, Riemer HJA; Chen, Wengen; Tubben, Alwin; Tingen, Hendrea SA; Davies, Daniel R; Grogan, Martha; Wechalekar, Ashutosh D; ... Chareonthaitawee, Panithaya; + view all (2023) Emerging Role of Scintigraphy Using Bone-Seeking Tracers for Diagnosis of Cardiac Amyloidosis: AJR Expert Panel Narrative Review. American Journal of Roentgenology , 222 (1) , Article e2329347. 10.2214/AJR.23.29347.

Suzuki, K; Wechalekar, AD; Kim, K; Shimazaki, C; Kim, JS; Ikezoe, T; Min, CK; ... Lu, J; + view all (2023) Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA. Annals of Hematology , 102 pp. 863-876. 10.1007/s00277-023-05090-z. Green open access
file

Tornatore, L; Capece, D; D'Andrea, D; Begalli, F; Verzella, D; Bennett, J; Acton, G; ... Franzoso, G; + view all (2019) Preclinical toxicology and safety pharmacology of the first-in-class GADD45β/MKK7 inhibitor and clinical candidate, DTP3. Toxicology Reports , 6 pp. 369-379. 10.1016/j.toxrep.2019.04.006. Green open access
file

Vergaro, Giuseppe; Castiglione, Vincenzo; Aimo, Alberto; Prontera, Concetta; Masotti, Silvia; Musetti, Veronica; Nicol, Martin; ... Fontana, Marianna; + view all (2023) N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis. European Journal of Heart Failure , 25 (3) pp. 335-346. 10.1002/ejhf.2769. Green open access
file

Vohra, Sargam Rachit; Ravichandran, Sriram; Foard, Darren; Martinez-Naharro, Ana; Venneri, Lucia; Fontana, Marianna; Whelan, Carol J; ... Wechalekar, Ashutosh D; + view all (2025) A retrospective study of isatuximab-pomalidomide-dexamethasone in relapsed/refractory systemic AL amyloidosis. [Letter]. Haematologica , 110 (12) pp. 3109-3113. 10.3324/haematol.2025.287664. Green open access
file

Wagner, T; Page, J; Burniston, M; Skillen, A; Ross, JC; Manwani, R; McCool, D; ... Wechalekar, AD; + view all (2018) Extracardiac 18F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds. European Journal of Nuclear Medicine and Molecular Imaging , 45 (7) pp. 1129-1138. 10.1007/s00259-018-3995-2. Green open access
file

Wechalekar, A; Antoni, G; Al Azzam, W; Bergström, M; Biswas, S; Chen, C; Cheriyan, J; ... Falk, RH; + view all (2022) Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study. BMC Cardiovascular Disorders , 22 , Article 49. 10.1186/s12872-021-02407-6. Green open access
file

Wechalekar, AD; (2021) The Evolving Epidemiology of Amyloidosis. JACC: CardioOncology , 3 (4) pp. 534-536. 10.1016/j.jaccao.2021.09.001. Green open access
file

Wechalekar, AD; Chakraborty, R; Lentzsch, S; (2020) Systemic Amyloidosis due to Low-Grade Lymphoma. Hematology/Oncology Clinics of North America , 34 (6) pp. 1027-1039. 10.1016/j.hoc.2020.08.016. Green open access
file

Wechalekar, AD; Sanchorawala, V; (2022) Daratumumab in AL amyloidosis. Blood , 140 (22) pp. 2317-2322. 10.1182/blood.2021014613. Green open access
file

Wechalekar, Ashutosh D; Cibeira, M Teresa; Gibbs, Simon D; Jaccard, Arnaud; Kumar, Shaji; Merlini, Giampaolo; Palladini, Giovanni; ... Kastritis, Efstathios; + view all (2022) Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group. Amyloid 10.1080/13506129.2022.2093635. (In press). Green open access
file

Wechalekar, AD; (2018) Biomarkers in AL amyloidosis: is the summit in sight? Blood , 131 (14) pp. 1502-1503. 10.1182/blood-2018-02-832113. Green open access
file

Wechalekar, AD; Gillmore, JD; Wassef, N; Lachmann, HJ; Whelan, C; Hawkins, PN; (2011) Abnormal N-terminal fragment of brain natriuretic peptide in patients with light chain amyloidosis without cardiac involvement at presentation is a risk factor for development of cardiac amyloidosis. Haematologica-Hematology Journal , 96 (7) 1079- 1080. 10.3324/haematol.2011.040493. Green open access
file

Wechalekar, AD; Whelan, C; (2017) Encouraging impact of doxycycline on early mortality in cardiac light chain (AL) amyloidosis. [Letter]. Blood Cancer Journal , 7 , Article e546. 10.1038/bcj.2017.26. Green open access
file

Wechalekar, K; Wechalekar, AD; (2021) Wild-type transthyretin cardiac amyloidosis: When is a rare disease no longer a rare disease? Journal of Nuclear Cardiology , 28 pp. 2857-2859. 10.1007/s12350-020-02275-1. Green open access
file

Wisniowski, B; Wechalekar, A; (2020) Confirming the Diagnosis of Amyloidosis. Acta Haematologica , 143 (4) pp. 312-321. 10.1159/000508022. Green open access
file

Wong, SW; Hegenbart, U; Palladini, G; Shah, GL; Landau, HJ; Warner, M; Toskic, D; ... Comenzo, RL; + view all (2018) Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p. Clinical Lymphoma, Myeloma and Leukemia , 18 (11) e493-e499. 10.1016/j.clml.2018.07.292. Green open access
file

Ziff, Monica; Lawson, Gabrielle; De-Silva, Dunnya; Cheesman, Simon; Kyriakou, Charalampia; Mahmood, Shameem; Papanikolaou, Xenofon; ... Popat, Rakesh; + view all (2021) Ixazomib with lenalidomide and dexamethasone for patients with relapsed multiple myeloma: impact of 17p deletion and sensitivity to proteasome inhibitors from a real world data-set. Leukemia & Lymphoma , 62 (5) pp. 1243-1246. 10.1080/10428194.2020.1864356. Green open access
file

Conference item

Law, S; Lachmann, H; Rezk, T; Wechalekar, A; Julian, G; Motallebzadeh, R; (2019) Outcome of Renal Transplantation in Systemic Amyloidosis. Presented at: 2019 American Transplant Congress, Boston, MA, USA. Green open access
file

Law, S; Lachmann, HJ; Rezk, T; Wechalekar, A; Gillmore, J; Motallebzadeh, R; (2019) Outcome of renal transplantation in systemic amyloidosis. Presented at: American Transplant Congress 2019, Boston, Massachusetts. Green open access
file

Martinez-Naharrro, A; Kotecha, T; Baggiano, A; Boldrini, M; Rezk, T; Knight, DS; Manwani, R; ... Fontana, M; + view all (2018) Assessment of Treatment Response in Cardiac AL Amyloidosis Using CMR Mapping - Results at 3 Months, 6 Months and 1 Year Post-Chemotherapy. Presented at: Imaging and Nuclear Medicine, Session Title: Melvin Judkins Young Investigator Competition. Green open access
file

This list was generated on Sun Dec 28 08:36:42 2025 GMT.